|
|
||||||||
Ann Thorac Surg 2007;84:1426-1427
© 2007 The Society of Thoracic Surgeons
a Division of Cardiovascular Surgery, St. Vincent Mercy Medical Center, 2213 Cherry St, ACC Bldg, Suite 309, Toledo, OH 43608
b Departments of Pediatrics and Medicine, University of Toledo, College of Medicine, Toledo, OH
c Division of Cardiovascular Surgery, St. Vincent Mercy Medical Center, 2213 Cherry St, ACC Bldg, Suite 309, Toledo, OH 43608
d Departments of Surgery, University of Toledo, College of Medicine, Toledo, OH 43699
(Email: robert_habib@mhsnr.org).
| The first 20% of the full text of this article appears below. |
To the Editor:
We read with great interest the article by Castiglioni and colleagues [1]. Their results, albeit based on 40 randomized patients, argue in favor of the minimally invasive closed circuit (MECC) cardiopulmonary bypass system (CPB). The difference in the hematocrit profiles and transfusion rates are impressive. The adverse effects of both excessive on-pump hemodilution and red blood cell transfusion on postoperative organ function and patient outcomes have been the focus of recent research [2, 3]. We noted that Castiglioni and colleagues [1] do not report a significant difference
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |